Related Experiment Videos
Photochemical inactivation of cell-associated human immunodeficiency virus in platelet concentrates
1Steritech Inc. Concord, CA.
Abstract:
Photochemical decontamination (PCD) of platelet concentrates, with adequate preservation of platelet function, has been shown using 8-methoxypsoralen (8-MOP) and long wavelength UV light (UVA). To further evaluate this technique, models for the inactivation of pathogenic human cell-associated viruses and integrated proviral sequences are required. We have assessed the ability of the PCD technique to inactivate cell-associated human immunodeficiency virus 1 (HIV-1) in platelet concentrates. We correlated PCD inhibition of HIV-1 infectivity with 8-MOP-DNA adduct formation in contaminating nucleated cells, and measured the inhibition of polymerase chain reaction (PCR)-mediated amplification of cellular DNA sequences as a surrogate for inactivation of integrated proviral nucleic acid sequences. After PCD treatment (8-MOP 300 micrograms/mL, UVA 17 mW/cm2) for 60 minutes, 0.5 x 10(6) plaque-forming units (PFU)/mL of cell-associated HIV-1 were inactivated and no virus was detectable by infectivity assay. After 60 minutes of PCD, 15 8-MOP-DNA adducts per 1,000 bp were formed, while in the absence of UVA, no adducts were formed. PCR-mediated amplification of a 242-bp cellular DNA sequence (HLA-DQ-alpha) was inhibited when greater than eight psoralen-DNA adducts per 1,000 bp were present. These studies indicate that high titers of cell-associated HIV-1 in platelet concentrates were inactivated by PCD, and the numbers of 8-MOP-DNA adducts in nucleated cells were sufficient to inhibit amplification of DNA segments that encode for as few as 80 amino acids. Based on the frequency of 8-MOP-DNA adducts, for the 10-kb HIV-1 genome, the probability of an integrated genome without at least one 8-MOP adduct after 60 minutes of PCD was 10(-33).
Insights
Photochemical decontamination (PCD) effectively inactivates cell-associated human immunodeficiency virus 1 (HIV-1) in platelet concentrates. The treatment creates psoralen-DNA adducts, preventing viral DNA amplification and ensuring blood product safety.
Area of Science:
- Virology
- Blood Product Safety
- Photochemistry
Background:
- Platelet concentrates require pathogen inactivation methods.
- Photochemical decontamination (PCD) using 8-methoxypsoralen (8-MOP) and UVA light preserves platelet function.
- Models are needed to assess PCD efficacy against cell-associated viruses and integrated proviral DNA.
Purpose of the Study:
- To evaluate the efficacy of PCD in inactivating cell-associated human immunodeficiency virus 1 (HIV-1) in platelet concentrates.
- To correlate PCD-induced 8-MOP-DNA adduct formation with viral inactivation.
- To measure the inhibition of DNA amplification as a surrogate for integrated proviral nucleic acid inactivation.
Main Methods:
- Platelet concentrates were treated with 8-MOP and UVA light.
- HIV-1 infectivity was assessed using plaque-forming unit assays.
- 8-MOP-DNA adducts in nucleated cells were quantified.
- Polymerase chain reaction (PCR) amplification of cellular DNA sequences was used to assess nucleic acid inactivation.
Main Results:
- PCD inactivated 0.5 x 10(6) PFU/mL of cell-associated HIV-1, with no detectable virus post-treatment.
- 15 8-MOP-DNA adducts per 1,000 bp were formed after 60 minutes of PCD.
- PCR amplification of a 242-bp DNA sequence was inhibited when >8 psoralen-DNA adducts per 1,000 bp were present.
- The probability of an intact HIV-1 genome was 10(-33) after treatment.
Conclusions:
- PCD effectively inactivates high titers of cell-associated HIV-1 in platelet concentrates.
- Sufficient 8-MOP-DNA adducts are formed to inhibit integrated proviral DNA amplification.
- PCD is a promising method for pathogen decontamination of platelet products.